A5081168476- Cancer therapeutics and mechanisms
- Pleural and Pulmonary Diseases
- Myasthenia Gravis and Thymoma
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Surgical site infection prevention
Thymomas and carcinomas of the thymus gland, also known as epithelial tumors (TT) are rare malignant neoplasms, but most common solid anterior mediastinum. The incidence does not exceed 1.3–1.7 per million inhabitants year. In Europe, about 1,500 new cases registered annually, average age patients is around 40–50 years. Originating from component thymus, primary lymphoid organ, they accompanied by a high risk developing autoimmune disorders due to their unique biology. Indeed, up 30 % TETS...
Lung cancer (LC) takes the first place in structure of overall oncology males. More than 1.8 million new cases lung are registered each year worldwide. LC is leading cause death both developing and developed countries, 5 years survival rate as low 19 %. Many factors explain such unsatisfactory outcomes, including diagnosis at an advanced stage, when currently available treatments can rarely provide cure. Non-small cell (NSCLC) with chromosomal rearrangement anaplastic lymphoma kinase (ALK)...
Lung resection is the main diagnostic and therapeutic surgical intervention in terms of lung cancer management. Air leak through pleural drains often occurs after resections due to damage pulmonary parenchyma. Therefore, proper drainage cavity very important for successful outcome operation. The installation a single anatomical resection, refusal use vacuum aspiration earliest possible removal contribute rapid activation patients postoperative period. Prolonged air leakage (PAL) on average,...